Peregrine Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.84M | Sell |
|
|||||
|
2025
Q2 | $7.67M | Buy |
|
|||||
|
2025
Q1 | $6.97M | Sell |
|
|||||
|
2024
Q4 | $7.38M | Buy |
|
|||||
|
2024
Q3 | $6.46M | Sell |
|
|||||
|
2024
Q2 | $7.03M | Buy |
|
|||||
|
2024
Q1 | $6.87M | Buy |
|
|||||
|
2023
Q4 | $6.75M | Sell |
|
|||||
|
2023
Q3 | $6.37M | Sell |
|
|||||
|
2023
Q2 | $7.73M | Sell |
|
|||||
|
2023
Q1 | $6.68M | Buy |
|
|||||
|
2022
Q4 | $7.43M | Sell |
|
|||||
|
2022
Q3 | $4.77M | Sell |
|
|||||
|
2022
Q2 | $5.41M | Sell |
|
|||||
|
2022
Q1 | $6.86M | Buy |
|
|||||
|
2021
Q4 | $4.51M | Buy |
|
|||||
|
2021
Q3 | $3.82M | Sell |
|
|||||
|
2021
Q2 | $9.37M | Buy |
|
|||||
|
2021
Q1 | $7.27M | Sell |
|
|||||
|
2020
Q4 | $11.9M | Buy |
|